首页> 美国卫生研究院文献>Genetic Testing and Molecular Biomarkers >Identification of miR-423 and miR-499 Polymorphisms on Affecting the Risk of Hepatocellular Carcinoma in a Large-Scale Population
【2h】

Identification of miR-423 and miR-499 Polymorphisms on Affecting the Risk of Hepatocellular Carcinoma in a Large-Scale Population

机译:miR-423和miR-499基因多态性对大规模人群肝细胞癌风险影响的鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aims: MicroRNAs (miRNAs) regulate gene expression and act as tumor suppressors or enhancers in oncogenesis. Single-nucleotide polymorphisms (SNPs) in miRNAs could alter the processing or actions of mature miRNA. So far, the association of miR-423 rs6505162 with cancers has not been explored, while the association of miR-499 rs3746444 was only reported in small-sized samples of different types of populations. Methods: To evaluate the association of miR-499 rs3746444 and miR-423 rs6505162 with hepatocellular carcinoma (HCC), we performed a large-scale case-control study of 984 patients with HCC and 991 cancer-free controls. Results: The risk of HCC was significantly higher with miR-499 rs3746444 TC+CC genotypes compared with those with the TT genotype (odds ratio [OR]=1.372, 95% confidence intervals [CI]=1.099–1.713, p=0.005), as was the risk of hepatitis B virus-related HCC (OR=1.437, 95% CI=1.128–1.831, p=0.003). Moreover, subjects with the TC+CC genotypes were more vulnerable to advanced HCC with larger tumor size (χ2=13.014, p=0.001) and/or higher total bilirubin (p=0.004), which suggested that a TT genotype or T allele might serve as a protective factor. miR-423 rs6505162 had no effect on the risk of HCC. Conclusions: miR-499 rs3746444 may contribute to the risk and prognosis of HCC, indicating that this SNP could be developed as a biomarker for HCC prediction.
机译:目的:MicroRNA(miRNA)调节基因表达,并在肿瘤发生中充当肿瘤抑制因子或增强因子。 miRNA中的单核苷酸多态性(SNP)可能会改变成熟miRNA的加工或作用。到目前为止,尚未探讨miR-423 rs6505162与癌症的关联,而miR-499 rs3746444的关联仅在不同类型人群的小样本中报道。方法:为了评估miR-499 rs3746444和miR-423 rs6505162与肝细胞癌(HCC)的关联,我们对984例HCC患者和991例无癌对照进行了大规模病例对照研究。结果:与TT基因型相比,miR-499 rs3746444 TC + CC基因型的HCC风险显着更高(几率[OR] = 1.372,95%置信区间[CI] = 1.099–1.713,p = 0.005) ,与乙肝病毒相关的HCC风险一样(OR = 1.437,95%CI = 1.128-1.831,p = 0.003)。此外,具有TC + CC基因型的受试者更容易受到晚期HCC的侵袭,肿瘤的大小更大(χ 2 = 13.014,p = 0.001)和/或总胆红素更高(p = 0.004),这表明TT基因型或T等位基因可能是保护因子。 miR-423 rs6505162对HCC的风险没有影响。结论:miR-499 rs3746444可能与HCC的风险和预后有关,表明该SNP可作为HCC预测的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号